Airway Management Devices Market (Product Type: Supraglottic Device, Infraglottic Device, Resuscitators, and Laryngoscope; Patient Age: Adult and Pediatric) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast by 2022-2027

IMARC Group's latest report, titled "Airway Management Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global airway management devices market size reached US$ 1.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2027, exhibiting a growth rate (CAGR) of 7.1% during 2022-2027.

Airway management devices are sets of medical procedures utilized for preventing patient airway obstruction. They are used in the maintenance or restoration of ventilation in a patient by executing extensive planning and evaluating various medical processes to treat patients with acute obstructions or respiratory failures. They ensure an open pathway in patients that aids in enabling the gas exchange between a patient's lungs and the atmosphere that are extensively utilized across hospitals, ambulatory surgery centers and home care. Some of the commonly adopted airway management devices to keep the upper airway open to provide unobstructed ventilation include tracheal intubation, airway clearance, supraglottic airway devices (SADs), and transtracheal access.

Competitive Landscape with Key Players:

The competitive landscape of the industry has also been examined along with the profiles of the key players being

• Ambu A/S
• Armstrong Medical Ltd
• Becton Dickinson and Company
• Flexicare (Group) Limited
• Intersurgical Ltd
• Medline Industries Inc
• Medtronic plc
• Mercury Enterprises Inc
• Smiths Group plc
• Teleflex Incorporated
• VBM Medizintechnik GmbH
• Verathon Inc. (Roper Technologies Inc.)

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/airway-management-devices-market/requestsample

Airway Management Devices Market Trends:

The growing prevalence of respiratory diseases among the masses majorly drives the global market. This can be attributed to the increasing number of individuals suffering from the chronic obstructive pulmonary disease (COPD) and asthma. Along with this, the widespread adoption of airway management devices due to their several benefits, such as maintenance of proper ventilation, high efficiency in airway clearance, and patient safety during operative procedures, is also significantly supporting the market. Due to the protracted treatment associated with lung diseases and the escalating need for emergency treatment for prolonged illnesses among children and adults are impacting the market favorably. Moreover, the advent of advanced techniques for preoperative airway evaluation, including preoperative endoscopic airway evaluation (PEAE), is creating a positive market outlook.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/airway-management-devices-market

Key Market Segmentation:

Breakup by Product:

• Supraglottic Devices
o Oropharyngeal Devices
o Naspharyngeal Devices
o Laryngeal Airway Devices
o Others
• Infraglottic Devices
o Endotracheal Tubes
o Tracheostomy Tubes
o Others
• Resuscitators
• Laryngoscopes
• Others

Breakup by Patient Type:

• Adult
• Pediatric Patient/Neonates

Breakup by Application:

• Anesthesia
• Emergency Medicine
• Others

Breakup by End Use:

• Hospitals
• Homecare
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse More Research Reports:

• https://www.imarcgroup.com/mobile-application-development-platform-market
• https://www.imarcgroup.com/tower-crane-market
• https://www.imarcgroup.com/preimplantation-genetic-testing-market
• https://www.imarcgroup.com/quantum-sensors-market
• https://www.imarcgroup.com/coagulation-analyzer-market

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800 Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.